Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| VU-VICC-SUPP-0723 | |||
| VU-VICC-070493 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
RATIONALE: Collecting information by questionnaire about the quality of life of patients with head and neck cancer may help doctors learn more about the disease.
PURPOSE: This clinical trial is testing a questionnaire for assessing pain control, head and neck symptoms, and general symptoms of illness, demographics, moods, alcohol and tobacco history, and quality of life related to cancer in patients with newly diagnosed head and neck cancer.
OBJECTIVES:
OUTLINE: Patients complete a timed questionnaire comprising questions of head and neck symptoms, demographic information, pain control, symptom control, mood, smoking and drinking history, and anxiety and depression under the supervision of the investigator.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| questionnaire administration | Other | Newly diagnosed HNC patients |
| |
| quality-of-life assessment | Procedure | following treatment |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pilot questionnaire testing of related symptoms, general demographics, pain control, general symptoms, mood, smoking and drinking history, and quality of life | collection of the following data from newly diagnosed HNC patients:
Questions will be identified that may be unclear or difficult for patients to understand for future revision. | at time of patient exam |
| Measure | Description | Time Frame |
|---|---|---|
| Time required for questionnaire completion by each patient | The investigator will verbally explain the purpose of the study using a script (provided with this packet) and obtain verbal consent from the patient. The questionnaire will be handed to the patient with instructions on how to complete it. The investigator will remain available in the room to address any concerns regarding the questionnaire and to time how long the patient takes to complete the survey. When the patient has completed the questionnaire, the investigator will review it for completeness with the patient. The patient's participation in the study ends at this time. |
Not provided
Inclusion Criteria:
Diagnosis of head or neck carcinoma
Able to speak English
Able to give informed consent
Exclusion Criteria:
Not specified
PRIOR CONCURRENT THERAPY:
Not provided
Not provided
Not provided
Newly diagnosed HNC patients.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Barbara Murphy, MD | Vanderbilt-Ingram Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232-6838 | United States |
Not provided
| ID | Term |
|---|---|
| D006258 | Head and Neck Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
| at time of patient exam |
| Feasibility and patient burden assessment | at time of patient exam |
| Baseline incidence of symptoms and psychosocial issues | at time of patient exam |